Apellis Pharmaceuticals, Inc. - FDA Approves SYFOVRE as the First and Only Treatment for Geographic...
WALTHAM - Apellis Pharmaceuticals, Inc. , a global biopharmaceutical company and leader in complement, today announced that the U.S. Food and Drug Administration has approved SYFOVRE for the...
marketscreener.com